Astellas Pharma Korea, Inc.
Clinical trials sponsored by Astellas Pharma Korea, Inc., explained in plain language.
-
Doctors track new stomach cancer Drug's Real-World side effects
Disease control Recruiting nowThis study is collecting information on the safety of VYLOY, an already approved drug, for people in South Korea with advanced stomach or gastroesophageal junction cancer that cannot be removed by surgery. About 377 patients receiving VYLOY as part of their standard care will be …
Sponsor: Astellas Pharma Korea, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Real-World watch: tracking a cancer Drug's performance in korea
Knowledge-focused Recruiting nowThis study aims to collect real-world information on the safety and effectiveness of PADCEV, a treatment for advanced bladder cancer. It will follow about 200 adult patients in South Korea who are already prescribed this drug by their doctors as part of their standard care. Resea…
Sponsor: Astellas Pharma Korea, Inc. • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC